Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation

v2.4.0.8
Share-Based Compensation
9 Months Ended
Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-Based Compensation

(3) SHARE-BASED COMPENSATION

For stock-based awards the Company recognized compensation expense based on the grant date fair value. Share-based compensation expense was $0.6 million and $3.3 million for the three months ended September 30, 2013 and 2012, respectively. Share-based compensation expense was $1.8 million and $10.0 million for the nine months ended September 30, 2013 and 2012, respectively.

Stock options granted pursuant to the 1998 Stock Option, Deferred Stock and Restricted Stock Plan and the 2007 Incentive Award Plan (the “Equity Incentive Plans”) were as follows:

 

     Shares     Weighted
Average
Exercise Price
     Weighted Average
Remaining
Contractual Term
   Aggregate
Intrinsic
Value
 

Outstanding at December 31, 2012

     52,696      $ 9.34       1.3 years    $ 482,916   

Granted

     0        0       0      0   

Exercised

     (7,750     10.34       0    $ 140,654   

Cancelled

     0        0       0      0   
  

 

 

         

Outstanding at September 30, 2013

     44,946        9.16       0.5 years    $ 986,477   
  

 

 

         

Exercisable at September 30, 2013

     44,946        9.16       0.5 years    $ 986,477   
  

 

 

         

A summary of the status and changes of our nonvested shares related to the Company’s Equity Incentive Plans as of and for the nine months ended September 30, 2013 is presented below:

 

     Shares     Weighted Average
Grant-Date Fair
Value
 

Nonvested at December 31, 2012

     284,333      $ 17.69   

Granted

     67,500        27.70   

Vested

     (8,167     23.57   

Cancelled

     0        0.00   
  

 

 

   

Nonvested at September 30, 2013

     343,666        19.52   
  

 

 

   

As of September 30, 2013, there was $5.5 million of unrecognized compensation cost related to nonvested common shares. The cost is expected to be amortized over a weighted average period of 3.0 years.